Intraductal injection of neoprene to suppress native pancreatic exocrine secretion in humans

Clinical and metabolic evaluation

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The management of exocrine pancreatic secretion represents an important technical problem in human segmental pancreatic transplantation. Among other methods, the suppression of exocrine secretion by duct injection with polymers is currently a widely accepted technique. Fibrosis induced by injected agents might be a possible cause of graft failure. In this report, we present metabolic data concerning endocrine pancreatic function in patients subjected to pancreaticoduodenectomy because of inflammatory or malignant diseases and injection of neoprene into the pancreatic duct to inhibit exocrine secretion from the residual pancreas. This procedure was used to avoid life-threatening complications that often occur after a pancreatico-digestive anastomosis.

Original languageEnglish
Pages (from-to)736-738
Number of pages3
JournalTransplantation Proceedings
Volume16
Issue number3
Publication statusPublished - 1984

Fingerprint

Neoprene
Injections
Pancreaticoduodenectomy
Pancreatic Ducts
Pancreas
Polymers
Fibrosis
Transplantation
Transplants

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

@article{0f747af966374cdcaac43113c25b19f1,
title = "Intraductal injection of neoprene to suppress native pancreatic exocrine secretion in humans: Clinical and metabolic evaluation",
abstract = "The management of exocrine pancreatic secretion represents an important technical problem in human segmental pancreatic transplantation. Among other methods, the suppression of exocrine secretion by duct injection with polymers is currently a widely accepted technique. Fibrosis induced by injected agents might be a possible cause of graft failure. In this report, we present metabolic data concerning endocrine pancreatic function in patients subjected to pancreaticoduodenectomy because of inflammatory or malignant diseases and injection of neoprene into the pancreatic duct to inhibit exocrine secretion from the residual pancreas. This procedure was used to avoid life-threatening complications that often occur after a pancreatico-digestive anastomosis.",
author = "{Di Carlo}, V. and R. Chiesa and Pontiroli, {A. E.}",
year = "1984",
language = "English",
volume = "16",
pages = "736--738",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Intraductal injection of neoprene to suppress native pancreatic exocrine secretion in humans

T2 - Clinical and metabolic evaluation

AU - Di Carlo, V.

AU - Chiesa, R.

AU - Pontiroli, A. E.

PY - 1984

Y1 - 1984

N2 - The management of exocrine pancreatic secretion represents an important technical problem in human segmental pancreatic transplantation. Among other methods, the suppression of exocrine secretion by duct injection with polymers is currently a widely accepted technique. Fibrosis induced by injected agents might be a possible cause of graft failure. In this report, we present metabolic data concerning endocrine pancreatic function in patients subjected to pancreaticoduodenectomy because of inflammatory or malignant diseases and injection of neoprene into the pancreatic duct to inhibit exocrine secretion from the residual pancreas. This procedure was used to avoid life-threatening complications that often occur after a pancreatico-digestive anastomosis.

AB - The management of exocrine pancreatic secretion represents an important technical problem in human segmental pancreatic transplantation. Among other methods, the suppression of exocrine secretion by duct injection with polymers is currently a widely accepted technique. Fibrosis induced by injected agents might be a possible cause of graft failure. In this report, we present metabolic data concerning endocrine pancreatic function in patients subjected to pancreaticoduodenectomy because of inflammatory or malignant diseases and injection of neoprene into the pancreatic duct to inhibit exocrine secretion from the residual pancreas. This procedure was used to avoid life-threatening complications that often occur after a pancreatico-digestive anastomosis.

UR - http://www.scopus.com/inward/record.url?scp=0021631107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021631107&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 736

EP - 738

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 3

ER -